The Trump Administration plan to destroy NEPA is dangerously wrong. Federal agencies need better funding, staffing, and training to engage in NEPA work more effectively; new short-cuts, time-limits, exemptions, or statutes of limitations are not in the public interest.
Trump’s “Gold Standard Science” executive order undermines scientific integrity by politicizing federal research, rolling back anti-interference protections, and enabling industry-friendly policies at the expense of public health and environmental studies.
Trump’s FDA cuts disbanded a key generic drug policy team, threatening progress on affordable alternatives to complex medications like Ozempic and inhalers—reversing $26B in consumer savings achieved during his first term.
Congressional Republicans’ proposed Medicaid work reporting requirements could strip coverage from hundreds of thousands of children, cost up to 449,000 jobs, and lead to more than 15,400 avoidable deaths each year.
Proposals to impose work requirements on Medicaid expansion enrollees would cause large coverage losses and hundreds of avoidable deaths each year in many congressional districts.
The US contributes disproportionately to drug development costs.
Balancing the budget without touching health care would require 40% cuts to all other federal spending. There is no practical way to balance the budget while sparing health care subsidies.
It’s one thing to let people opt out of fluoride; it’s another to block access for those who want it.
President Trump’s NOAA cuts will significantly hamper the public’s understanding of the environment and weather forecasting, negatively affecting people in the United States and abroad.
Health and Human Services Secretary Robert F. Kennedy Jr’s decision to remove COVID-19 vaccines from the CDC’s immunization schedule for healthy pregnant women and children is profoundly alarming, argues epidemiologist
